Robert J. Bitterman - Dec 14, 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Interim Executive Chairman, Director
Signature
Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Dec 14, 2022
Transactions value $
$780
Form type
4
Date filed
12/15/2022, 04:00 PM
Previous filing
Dec 8, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $780 +2K +2.76% $0.39 74.5K Dec 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.